North America Remote Patient Monitoring Market Research Report - Segmented By Type (Breath Monitors, Physical Activity Monitors, Heart Monitors, Hematological Monitors, Multi-Sign Monitors), Application, End-Use & Country (The United States, Canada and Rest of North America) - Industry Analysis From 2024 to 2033
The North America remote patient monitoring market is anticipated to rise from USD 1876 million in 2024 to USD 5814 million in 2033, growing at a CAGR of 13.39%.
Remote Patient Monitoring (RPM) refers to the digital technologies enabling the continuous or intermittent collection of physiological data from patients outside traditional clinical settings, including homes, long-term care facilities, and ambulatory environments. These systems utilize connected devices such as wearable ECG monitors, glucose trackers, blood pressure cuffs, and pulse oximeters to transmit real-time health metrics to healthcare providers for proactive intervention. As per the American Heart Association, 121.5 million American adults live with some form of cardiovascular disease, creating a vast base for chronic condition monitoring. Additionally, the National Institute of Diabetes and Digestive and Kidney Diseases notes that 38.4 million Americans have been diagnosed with diabetes, a condition highly amenable to remote glucose and insulin tracking, reinforcing the clinical necessity and scalability of RPM solutions.
Expansion of Medicare and private insurer reimbursement for remote monitoring services is a pivotal driver accelerating RPM adoption across North America. This policy shift has incentivized healthcare systems to integrate RPM into standard care pathways, particularly for chronic disease management. Private insurers, including UnitedHealthcare and Aetna, have followed suit, covering RPM for conditions such as heart failure, COPD, and diabetes.
The rising prevalence of chronic diseases and aging population dynamics are intensifying demand for continuous, decentralized care models. According to the CDC, six in ten American adults have at least one chronic disease, with four in ten living with multiple conditions, factors that necessitate frequent clinical oversight. The U.S. Census Bureau projects that by 2030, nearly 21% of the U.S. population will be aged 65 or older, a demographic with higher rates of hypertension, diabetes, and cardiac arrhythmias. In Canada, as per the Statistics Canada, 89% of healthcare expenditures are linked to chronic conditions, prompting provincial health authorities to adopt RPM to reduce system strain. This confluence of demographic and epidemiological trends is making RPM not just a convenience, but a clinical and economic imperative across the healthcare continuum.
Fragmented regulatory and interoperability standards across health IT systems significantly hinder seamless RPM integration. The lack of universal data formats and device certification protocols creates inconsistencies in data quality and clinical usability. Like, physicians often face challenges with integrating RPM data into their workflows, leading to alert fatigue and potential burnout.
Persistent disparities in broadband access and digital literacy among vulnerable populations restrict equitable RPM deployment. According to the Federal Communications Commission (FCC), millions of Americans lack access to broadband internet, with rural, low-income, and elderly populations disproportionately affected. In Indigenous communities across North America, including First Nations reserves in Canada and tribal lands in the U.S., connectivity gaps are even more pronounced, with some regions reporting internet speeds below 5 Mbps. These infrastructural and educational barriers undermine the scalability and inclusivity of RPM programs.
Integration of artificial intelligence and predictive analytics into RPM platforms presents a transformative opportunity for early intervention and personalized care. Companies like Current Health and Biofourmis have developed machine learning models that identify subtle physiological deviations before symptoms manifest. These advancements enable risk stratification, dynamic care planning, and reduced clinician workload, positioning AI as a cornerstone of next-generation remote care.
Expansion of RPM into post-acute and surgical recovery care pathways is unlocking new clinical applications beyond chronic disease. According to the American College of Surgeons, over 50 million surgical procedures are performed annually in the U.S., with postoperative complications affecting 15% of patients. In response, hospitals are adopting RPM to monitor vital signs, wound healing, and medication adherence after discharge. In 2023, the Cleveland Clinic reported a reduction in 30-day readmissions for joint replacement patients using remote monitoring. Additionally, the Veterans Health Administration has deployed RPM for over 120,000 post-surgical veterans, improving access for rural populations. This shift transforms RPM from a chronic care tool into a comprehensive recovery management system, broadening its clinical relevance and reimbursement potential.
Cybersecurity vulnerabilities and patient data privacy concerns pose significant challenges to widespread RPM adoption. The average cost of a healthcare data breach reached $10.93 million in 2023, the highest across all industries. Many consumer-grade RPM devices lack HIPAA compliance or end-to-end encryption, raising regulatory and ethical concerns. As the number of connected devices grows, ensuring robust cybersecurity protocols and transparent consent mechanisms becomes critical to maintaining patient trust and regulatory compliance.
Provider resistance and workflow integration challenges within clinical settings remain a critical barrier to RPM scalability. Integrating RPM into existing electronic health records often requires additional staff training and workflow redesign, which smaller practices cannot afford. Additionally, inconsistent billing practices and a lack of standardized care protocols create confusion among providers. Without streamlined integration and clear return-on-investment metrics, many healthcare organizations remain hesitant to fully adopt RPM despite its demonstrated clinical benefits.
The Heart Monitors segment dominated the North America Remote Patient Monitoring (RPM) market by capturing a 36.3% of the total value in 2024. This position is anchored in the high prevalence of cardiovascular conditions and the critical need for continuous cardiac rhythm and hemodynamic tracking outside hospital settings. The high incidence of arrhythmias and post-event cardiac care requirements is a primary driver of this segment’s dominance. Implantable loop recorders and wearable ECG patches, such as those from Abbott and AliveCor, are now standard in post-discharge protocols for myocardial infarction and heart failure. The Centers for Medicare & Medicaid Services (CMS) reimburses for CPT code 93298 (remote monitoring of implantable devices), driving adoption across cardiology practices. This clinical necessity, combined with strong reimbursement, solidifies heart monitors as the most entrenched RPM modality. A further critical factor is the integration of heart monitors into preventive and ambulatory care pathways. Wearables like the Apple Watch and Fitbit have expanded access to single-lead ECGs. These consumer devices act as early screening tools, funneling high-risk individuals into formal care.
The Multi-Sign Monitors segment is the fastest-growing segment and is projected to expand at a CAGR of 14.7% from 2025 to 2033. These devices simultaneously track two or more vital parameters, such as heart rate, SpO₂, respiratory rate, and temperature, enabling comprehensive patient assessment in a single platform. A key driver is the rising demand for holistic, risk-stratified monitoring in post-acute and high-risk chronic care. Multi-sign monitors allow clinicians to detect early deterioration through integrated data trends. A further critical factor is the adoption of hospital-at-home and virtual acute care models. These platforms integrate with electronic health records (EHRs) via FHIR standards, enabling real-time alerts and clinician dashboards.
The Cardiovascular Diseases application segment held the largest share at 41.3% of the market in 2024. This dominance is due to the high burden of heart disease, the need for continuous monitoring, and well-established reimbursement pathways. A main driver is the sheer scale of cardiovascular disease prevalence and associated healthcare costs. According to the American Heart Association, cardiovascular diseases affect 121.5 million American adults and cost the U.S. healthcare system $229 billion annually. Conditions such as heart failure, hypertension, and arrhythmias require ongoing physiological tracking to prevent complications. CMS reimbursement for remote monitoring of implantable cardiac devices has further incentivized adoption. A different critical factor is the deep integration of RPM into cardiology care standards and clinical workflows. The American College of Cardiology recommends remote monitoring for all patients with implantable cardioverter-defibrillators (ICDs) or pacemakers, a group exceeding 1.2 million in the U.S. Additionally, wearable ECG patches from companies like BioTelemetry are used for extended rhythm monitoring in undiagnosed syncope cases. This clinical entrenchment, supported by evidence-based guidelines and payer policies, ensures cardiovascular RPM remains the cornerstone of the market.
The fastest-growing application segment is Diabetes Treatment and is projected to grow at a CAGR of 13.9% during the forecast period. This surge is driven by the rising prevalence of diabetes and the transformative impact of continuous glucose monitoring (CGM) technologies. A key driver is the expansion of CGM adoption and insurance coverage for remote glucose tracking. Another critical factor is the integration of CGM with insulin delivery and AI-driven decision support. Additionally, telehealth platforms like Teladoc now offer end-to-end diabetes management programs centered on RPM, enabling scalable, personalized care for a growing patient base.
The Home Healthcare segment led the end-use category by accounting for 53.5% of total RPM utilization in 2024. This dominance reflects the shift toward decentralized care, patient preference for home-based treatment, and supportive reimbursement policies. A primary driver is the expansion of Medicare’s Chronic Care Management (CCM) and Remote Therapeutic Monitoring (RTM) programs. Another critical factor is the growing consumer demand for autonomy and comfort in health management. RPM enables aging in place while ensuring clinical oversight. Devices like wireless blood pressure cuffs, pulse oximeters, and weight scales are user-friendly and integrate with smartphone apps, enhancing adherence. This alignment of clinical efficacy, patient preference, and economic efficiency solidifies home healthcare as the dominant RPM environment.
The Hospitals segment is the fastest-growing end-use segment and is projected to expand at a CAGR of 12.4% from 2025 to 2033. This growth is fueled by the adoption of RPM in inpatient monitoring, step-down units, and hospital-at-home models. A major driver is the implementation of hospital-at-home programs that extend acute care into the home via hospital-led RPM. These programs rely on hospital-based care teams using centralized dashboards to manage remote patients, blurring the line between inpatient and outpatient monitoring. A different critical factor is the integration of RPM into post-discharge and transitional care protocols. This institutional investment in digital infrastructure positions hospitals as active orchestrators of remote care, not just referral sources.
The United States held a commanding position in the North American remote Patient Monitoring market by capturing a substantial share of total regional value in 2024. As the largest and most advanced healthcare market in the region, the U.S. benefits from robust reimbursement policies, a high prevalence of chronic diseases, and widespread adoption of digital health technologies.
Canada is establishing itself as a progressive adopter with a strong public health infrastructure and growing investment in digital care. Provincial health authorities in Ontario, British Columbia, and Alberta have launched pilot RPM programs for chronic disease management. The Canadian Agency for Drugs and Technologies in Health (CADTH) has issued positive reviews for several RPM devices, facilitating adoption. However, interprovincial data sharing remains limited due to fragmented health IT systems.
A few of the major participants operating in the North American remote patient monitoring market profiled in this report are Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc., Honeywell, American Telecare, Biotronik, and Covidien PLC.
The competitive landscape of the North America Remote Patient Monitoring market is defined by a convergence of medical device giants, digital health innovators, and healthcare delivery platforms vying for dominance in a rapidly evolving care model. Established players like Philips and Medtronic leverage clinical credibility and deep provider relationships, while agile startups such as Current Health and Biofourmis lead in AI-driven analytics and hospital-at-home integration. Competition is intensifying around data accuracy, interoperability, and ease of use, with differentiation increasingly tied to predictive capabilities and care coordination. Reimbursement alignment, cybersecurity, and regulatory clearance are critical barriers to entry. The market is shifting from standalone devices to end-to-end care ecosystems, where value is measured by clinical outcomes, cost savings, and patient engagement, reshaping competitive advantage across technology, service, and operational domains.
Philips plays a pivotal role in shaping the North America Remote Patient Monitoring (RPM) landscape through its integrated portfolio of connected care solutions, including wearable biosensors, telehealth platforms, and enterprise monitoring systems. The company has localized its offerings to meet U.S. and Canadian regulatory standards, with its eICU program deployed in over 120 hospitals to support virtual critical care. The company also expanded its partnership with the Veterans Health Administration to scale home-based RPM for chronic disease patients. Additionally, Philips integrated its RPM data with Epic and Cerner EHRs, ensuring seamless clinical workflow adoption. Its focus on interoperability, predictive analytics, and patient-centric design reinforces its leadership in both acute and home care environments.
Medtronic is a leading contributor to the RPM market through its advanced remote monitoring systems for cardiac and diabetes care. The company’s CareLink and MyCareLink platforms enable real-time transmission of data from pacemakers, ICDs, and insulin pumps, allowing clinicians to detect arrhythmias or glucose fluctuations before complications arise. The company also launched the MiniMed 780G insulin pump with SmartGuard™ technology, which uses predictive algorithms to automate insulin delivery based on CGM trends. Medtronic strengthened its position by collaborating with health systems like Mayo Clinic to integrate RPM into hospital-at-home programs. Its deep clinical validation and long-standing relationships with cardiology and endocrinology practices ensure sustained trust and adoption.
Current Health, a Best Buy Health company, has emerged as a key innovator by redefining hospital-at-home and post-acute care through its all-in-one RPM platform. The company provides a tablet-based hub that connects to multi-parameter devices—measuring blood pressure, SpO₂, heart rate, temperature, and weight—enabling comprehensive patient monitoring outside clinical settings. The company also introduced AI-powered deterioration indices that predict clinical decline up to 48 hours in advance. Its platform integrates with major EHRs and supports nurse-led virtual care teams, ensuring scalability. By combining hardware, software, and care coordination, Current Health has positioned itself at the forefront of decentralized acute care delivery in North America.
Key players in the North America Remote Patient Monitoring market are leveraging clinical integration, regulatory compliance, and technological innovation to strengthen their market presence. Companies are focusing on seamless EHR interoperability to ensure RPM data flows directly into clinician workflows, reducing alert fatigue and improving usability. Strategic partnerships with health systems, payers, and home health agencies are enabling large-scale deployment in chronic and acute care programs. Investment in AI and predictive analytics enhances early intervention capabilities, increasing clinical value. Expansion into hospital-at-home and post-discharge models allows providers to extend care beyond facility walls. Additionally, firms are prioritizing user experience, data security, and HIPAA-compliant platforms to build trust among patients and providers. Reimbursement alignment with CMS and private insurers is a core focus, ensuring financial sustainability and scalability across diverse care settings.
This research report on the North American remote patient monitoring market has been segmented and sub-segmented into the following categories.
By Type
By Application
By End-Use
By Country
Frequently Asked Questions
The COVID-19 pandemic has accelerated the adoption of remote patient monitoring in Canada, with a notable increase in demand for virtual healthcare solutions.
Technological advancements such as the development of advanced sensors, improved connectivity, and real-time data analytics are driving growth in the North American remote patient monitoring market.
The Mexican government has implemented initiatives to promote the adoption of remote patient monitoring, including funding programs and policy support for healthcare organizations.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region